GLP-3 RT 10mg Peptides

Crafted for disciplined research, this lyophilized peptide arrives ready for precise, reproducible work at the bench.

Better Molecule GLP-3 RT is presented as a lyophilized research vial with a neutral, unflavored profile. This GLP-class peptide is supplied at a total content of 10mg per vial, designed for controlled handling and consistent performance across assays and method development.

  • 10mg GLP-3 RT – supports investigation of receptor interactions, downstream signaling, and stability characteristics in controlled laboratory models, enabling clear, repeatable data capture.

This non-edible format is intended for qualified professionals. The freeze-dried presentation supports convenient storage, accurate weighing, and clean reconstitution using an appropriate sterile diluent. When handled in accordance with established laboratory practices, the uniform cake structure is formulated for reliable dissolution and consistent aliquoting, helping maintain integrity across replicates and time points.

Every vial is produced with careful attention to material identity and handling from start to finish. Lots are prepared in controlled environments with standardized fill volumes and drying conditions to promote batch-to-batch consistency. Each lot undergoes analytical verification, including HPLC and LC-MS methods for identity and purity assessment, with results recorded for traceability. Packaging is clean, secure, and labeled for straightforward inventory management in research settings.

Storage and handling should follow standard laboratory guidance for peptides. Maintain the sealed, dry state protected from light and temperature excursions. After reconstitution, researchers may aliquot to minimize freeze-thaw cycles and preserve performance characteristics over the duration of a study. Do not combine with incompatible materials, and consult internal protocols for specific assay requirements.

Better Molecule is a USA-based supplier focused on quality, transparency, and control. We prioritize premium raw materials, rigorous analytical testing, and exacting documentation so researchers can work with confidence. GLP-3 RT is intended strictly for laboratory research use only, not for human consumption, medical, veterinary, or other non-laboratory applications. For institutions requiring records, lot-level documentation is maintained and available upon request to support compliance and method validation workflows.

Total Strength
10mg
Strength Per vial
10mg/vial
Total Units
1 vial
Weight
0.70oz
Total GLP-3 RT Compounds
10mg
GLP-3 RT Compounds Per vial
10mg/vial

View
GLP-3 RT 10mg Peptides

  • Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
  • Shipping is free on orders of $99+ (except Hawaii and Alaska).
  • All orders ship in discreet packaging via USPS Ground Advantage mail.

Delivery restrictions vary by state.

Also Available In Research Kits

Related Products

Customer Reviews

There are no reviews yet. Be the first to write a review!

Frequently Asked Questions

What is GLP-3 RT?

GLP-3 RT is not a standard pharmacology name, and on research-vendor sites it is often used as shorthand for a retatrutide-style multi-incretin compound. Because that naming is vendor-dependent, the exact identity should be checked on the product page or certificate of analysis. It should therefore be described cautiously as a multi-pathway metabolic research compound.

What is GLP-3 RT typically studied for?

Compounds sold under this label are generally discussed for appetite, glucose regulation, energy expenditure, and multi-receptor incretin signaling. A careful FAQ should avoid presenting the shorthand as if it were a formal drug name and instead tell readers to verify the exact active ingredient before designing research around it.

What are GLP peptides?

GLP peptides — glucagon-like peptides — are a family of peptides derived from the post-translational processing of the proglucagon precursor. The main members are GLP-1 and GLP-2, both of which are produced primarily by intestinal L-cells. GLP-1 is studied in the context of insulin secretion, glucose metabolism, and appetite signaling, while GLP-2 is investigated for its role in intestinal epithelial biology.

A number of synthetic analogs and research compounds exist in this category, including semaglutide-class and tirzepatide-class sequences, as well as dual- and triple-agonist research peptides. All GLP peptide products from Better Molecule are lyophilized research materials intended solely for in vitro laboratory investigation.

How do GLP analogs differ from native GLP hormones?

Native GLP-1 has a very short half-life in plasma — on the order of a few minutes — because it is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4). GLP analogs are engineered peptides that modify the native sequence or attach additional groups such as fatty acid chains, in order to resist DPP-4 degradation, extend half-life, and optimize receptor binding.

This extended stability is what makes GLP analogs useful in research as practical tools for studying the GLP-1 and related receptor systems in controlled experiments. The analogs differ from native GLP hormones primarily in their pharmacokinetic profile and, in some cases, their receptor selectivity across the GLP-1, GIP, and glucagon receptor families.

What is the difference between GLP-1, GLP-2, and GLP-3 in research?

GLP-1 and GLP-2 are both produced from the proglucagon precursor. GLP-1 is studied in connection with the GLP-1 receptor, insulin secretion, and appetite signaling, while GLP-2 is studied primarily in connection with the GLP-2 receptor and intestinal epithelial biology. The two peptides share a common precursor but have different receptor targets and research focuses.

GLP-3 is not a classical endogenous peptide in the same way as GLP-1 and GLP-2. The term is sometimes used as a research label for engineered or triple-agonist peptides that combine activity at GLP-1, GIP, and glucagon receptors in a single molecule. In this sense, GLP-3 in research usually refers to a designed multi-target compound rather than a naturally occurring hormone.

Recently Viewed